|
1
|
Loibl S, Poortmans P, Morrow M, Denkert C
and Curigliano G: Breast cancer. Lancet. 397:1750–1769. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ginsburg O, Bray F, Coleman MP, Vanderpuye
V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, et
al: The global burden of women's cancers: A grand challenge in
global health. Lancet. 389:847–860. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kreso A and Dick JE: Evolution of the
cancer stem cell model. Cell Stem Cell. 14:275–291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta PB, Fillmore CM, Jiang G, Shapira
SD, Tao K, Kuperwasser C and Lander ES: Stochastic state
transitions give rise to phenotypic equilibrium in populations of
cancer cells. Cell. 146:633–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng F, Li TT, Wang KL, Xiao GQ, Wang JH,
Zhao HD, Kang ZJ, Fan WJ, Zhu LL, Li M, et al: H19/let-7/LIN28
reciprocal negative regulatory circuit promotes breast cancer stem
cell maintenance. Cell Death Dis. 8:e25692017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Charafe-Jauffret E, Ginestier C, Bertucci
F, Cabaud O, Wicinski J, Finetti P, Josselin E, Adelaide J, Nguyen
TT, Monville F, et al: ALDH1-positive cancer stem cells predict
engraftment of primary breast tumors and are governed by a common
stem cell program. Cancer Res. 73:7290–7300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rankin S, Ayad NG and Kirschner MW:
Sororin, a substrate of the anaphase-promoting complex, is required
for sister chromatid cohesion in vertebrates. Mol Cell. 18:185–200.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gaudet P, Livstone MS, Lewis SE and Thomas
PD: Phylogenetic-based propagation of functional annotations within
the Gene Ontology consortium. Brief Bioinform. 12:449–462. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schmitz J, Watrin E, Lénárt P, Mechtler K
and Peters JM: Sororin is required for stable binding of cohesin to
chromatin and for sister chromatid cohesion in interphase. Curr
Biol. 17:630–636. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishiyama T, Ladurner R, Schmitz J, Kreidl
E, Schleiffer A, Bhaskara V, Bando M, Shirahige K, Hyman AA,
Mechtler K and Peters JM: Sororin mediates sister chromatid
cohesion by antagonizing Wapl. Cell. 143:737–749. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Watrin E, Demidova M, Watrin T, Hu Z and
Prigent C: Sororin pre-mRNA splicing is required for proper sister
chromatid cohesion in human cells. EMBO Rep. 15:948–955. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boyle MI, Jespersgaard C, Nazaryan L, Ravn
K, Brøndum-Nielsen K, Bisgaard AM and Tümer Z: Deletion of
11q12.3-11q13.1 in a patient with intellectual disability and
childhood facial features resembling Cornelia de Lange syndrome.
Gene. 572:130–134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Safran M, Rosen N, Twik M, BarShir R,
Stein TI, Dahary D, Fishilevich S and Lancet D: The GeneCards
Suite. Practical Guide Life Sci Databases; pp. 27–56. 2021
|
|
16
|
Nguyen MH, Koinuma J, Ueda K, Ito T,
Tsuchiya E, Nakamura Y and Daigo Y: Phosphorylation and activation
of cell division cycle associated 5 by mitogen-activated protein
kinase play a crucial role in human lung carcinogenesis. Cancer
Res. 70:5337–5347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang IW, Lin VC, He HL, Hsu CT, Li CC, Wu
WJ, Huang CN, Wu TF and Li CF: CDCA5 overexpression is an indicator
of poor prognosis in patients with urothelial carcinomas of the
upper urinary tract and urinary bladder. Am J Transl Res.
7:710–722. 2015.PubMed/NCBI
|
|
18
|
Tokuzen N, Nakashiro K, Tanaka H, Iwamoto
K and Hamakawa H: Therapeutic potential of targeting cell division
cycle associated 5 for oral squamous cell carcinoma. Oncotarget.
7:2343–2353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Z, Shen M and Zhou G: Upregulation
of CDCA5 promotes gastric cancer malignant progression via
influencing cyclin E1. Biochem Biophys Res Commun. 496:482–489.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen T, Huang Z, Tian Y, Wang H, Ouyang P,
Chen H, Wu L, Lin B and He R: Role of triosephosphate isomerase and
downstream functional genes on gastric cancer. Oncol Rep.
38:1822–1832. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen Z, Yu X, Zheng Y, Lai X, Li J, Hong
Y, Zhang H, Chen C, Su Z and Guo R: CDCA5 regulates proliferation
in hepatocellular carcinoma and has potential as a negative
prognostic marker. Onco Targets Ther. 11:891–901. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B and Varambally
S: UALCAN: A portal for facilitating tumor subgroup gene expression
and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Győrffy B: Survival analysis across the
entire transcriptome identifies biomarkers with the highest
prognostic power in breast cancer. Comput Struct Biotechnol J.
19:4101–4109. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vasaikar SV, Straub P, Wang J and Zhang B:
LinkedOmics: Analyzing multi-omics data within and across 32 cancer
types. Nucleic Acids Res. 46:D956–D963. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:(Database Issue). D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dontu G, Abdallah WM, Foley JM, Jackson
KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and
transcriptional profiling of human mammary stem/progenitor cells.
Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saadin K and White IM: Breast cancer stem
cell enrichment and isolation by mammosphere culture and its
potential diagnostic applications. Expert Rev Mol Diagn. 13:49–60.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin Y, Hou Y, Liu S, Zhu P, Wan X, Zhao M,
Peng M, Zeng H, Li Q, Jin T, et al: A Novel long non-coding RNA
lnc030 maintains breast cancer stem cell stemness by stabilizing
SQLE mRNA and increasing cholesterol synthesis. Adv Sci (Weinh).
8:20022322021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ai L, Mu S, Sun C, Fan F, Yan H, Qin Y,
Cui G, Wang Y, Guo T, Mei H, et al: Myeloid-derived suppressor
cells endow stem-like qualities to multiple myeloma cells by
inducing piRNA-823 expression and DNMT3B activation. Mol Cancer.
18:882019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang T, Guo C, Xia T, Zhang R, Zen K, Pan
Y and Jin L: LncCCAT1 promotes breast cancer stem cell function
through activating WNT/β-catenin signaling. Theranostics.
9:7384–7402. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma XL, Hu B, Tang WG, Xie SH, Ren N, Guo L
and Lu RQ: CD73 sustained cancer-stem-cell traits by promoting SOX9
expression and stability in hepatocellular carcinoma. J Hematol
Oncol. 13:112020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dominguez-Brauer C, Thu KL, Mason JM,
Blaser H, Bray MR and Mak TW: Targeting mitosis in cancer: Emerging
strategies. Mol Cell. 60:524–536. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
López-Lázaro M: The stem cell division
theory of cancer. Crit Rev Oncol Hematol. 123:95–113. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang N and Pati D: Sororin is a master
regulator of sister chromatid cohesion and separation. Cell Cycle.
11:2073–2083. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen H, Chen J, Zhao L, Song W, Xuan Z,
Chen J, Li Z, Song G, Hong L, Song P and Zheng S: CDCA5,
transcribed by E2F1, promotes oncogenesis by enhancing cell
proliferation and inhibiting apoptosis via the AKT pathway in
hepatocellular carcinoma. J Cancer. 10:1846–1854. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tian Y, Wu J, Chagas C, Du Y, Lyu H, He Y,
Qi S, Peng Y and Hu J: CDCA5 overexpression is an Indicator of poor
prognosis in patients with hepatocellular carcinoma (HCC). BMC
Cancer. 18:11872018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Xia C, Pu M, Dai B, Yang X, Shang
R, Yang Z, Zhang R, Tao K and Dou K: Silencing of CDCA5 inhibits
cancer progression and serves as a prognostic biomarker for
hepatocellular carcinoma. Oncol Rep. 40:1875–1884. 2018.PubMed/NCBI
|
|
38
|
Fu G, Xu Z, Chen X, Pan H, Wang Y and Jin
B: CDCA5 functions as a tumor promoter in bladder cancer by
dysregulating mitochondria-mediated apoptosis, cell cycle
regulation and PI3k/AKT/mTOR pathway activation. J Cancer.
11:2408–2420. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ji J, Shen T, Li Y, Liu Y, Shang Z and Niu
Y: CDCA5 promotes the progression of prostate cancer by affecting
the ERK signalling pathway. Oncol Rep. 45:921–932. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang X, Huang Y, Lv Z, Wang T, Feng H,
Wang H, Du S, Wu S, Shen D, Wang C, et al: Loss of cell division
cycle-associated 5 promotes cell apoptosis by activating DNA damage
response in clear cell renal cell carcinoma. Int J Oncol.
61:872022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Phan NN, Wang CY, Li KL, Chen CF, Chiao
CC, Yu HG, Huang PL and Lin YC: Distinct expression of CDCA3,
CDCA5, and CDCA8 leads to shorter relapse free survival in breast
cancer patient. Oncotarget. 9:6977–6992. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jin X, Wang D, Lei M, Guo Y, Cui Y, Chen
F, Sun W and Chen X: TPI1 activates the PI3K/AKT/mTOR signaling
pathway to induce breast cancer progression by stabilizing CDCA5. J
Transl Med. 20:1912022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang Y, Yao J, Zhu Y, Zhao X, Lv J and Sun
F: Knockdown of CDCA5 suppresses malignant progression of breast
cancer cells by regulating PDS5A. Mol Med Rep. 25:2092022.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gerger A, Zhang W, Yang D, Bohanes P, Ning
Y, Winder T, LaBonte MJ, Wilson PM, Benhaim L, Paez D, et al:
Common cancer stem cell gene variants predict colon cancer
recurrence. Clin Cancer Res. 17:6934–6943. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fabrizi E, di Martino S, Pelacchi F and
Ricci-Vitiani L: Therapeutic implications of colon cancer stem
cells. World J Gastroenterol. 16:3871–3877. 2010. View Article : Google Scholar : PubMed/NCBI
|
